Hepatitis C screening trends in a large integrated health system
- PMID: 24486288
- PMCID: PMC3999187
- DOI: 10.1016/j.amjmed.2014.01.012
Hepatitis C screening trends in a large integrated health system
Abstract
Background: As new hepatitis C virus (HCV) therapies emerge, only 1%-12% of individuals are screened in the US for HCV infection. Presently, HCV screening trends are unknown.
Methods: We utilized the Kaiser Permanente Mid-Atlantic States' (KPMAS) data repository to investigate HCV antibody screening between January 1, 2003 and December 31, 2012. We identified the proportion screened for HCV and 5-year cumulative incidence of screening, the screening positivity rate, the provider types performing HCV screening, patient-level factors associated with being screened, and trends in screening over time.
Results: There were 444,594 patients who met the inclusion criteria. Overall, 15.8% of the cohort was ever screened for HCV. Adult primary care and obstetrics and gynecology providers performed 75.9% of all screening. The overall test positivity rate was 3.8%. Screening was more frequent in younger age groups (P <.0001) and those with a documented history of illicit drug use (P <.0001). Patients with missing drug use history (46.7%) were least likely to be screened (P <.0001). While the rate of HCV screening increased in the later years of the study among those enrolled in KPMAS 2009-2012, only 11.8% were screened by the end of follow-up.
Conclusion: Screening for HCV is increasing but remains incomplete. Targeting screening to those with a history of injection drug will not likely expand screening, as nearly half of patients have no documented drug use history. Routine screening is likely the most effective approach to expand HCV screening.
Keywords: Hepatitis C virus; Screening rates; Screening trends.
Copyright © 2014. Published by Elsevier Inc.
Conflict of interest statement
The authors declare that they have no conflicts of interest. All authors had access to the data and a role in writing the manuscript.
Figures
References
-
- Wise M, Bialek S, Finelli L, Bell BP, Sorvillo F. Changing trends in hepatitis C-related mortality in the United States, 1995–2004. Hepatology (Baltimore Md.) 2008 Apr;47(4):1128–1135. - PubMed
-
- Centers for Disease Control and Prevention. Disease Burden from Viral Hepatitis A, B, and C in the United States. [Accessed May 15, 2013]; Available at: http://www.cdc.gov/hepatitis/HCV/StatisticsHCV.htm.
-
- Smith BD, Morgan RL, Beckett GA, et al. Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945–1965. MMWR. Morbidity and mortality weekly report. 2012 Aug 17;61(RR-4):1–32. - PubMed
-
- Roblin DW, Smith BD, Weinbaum CM, Sabin ME. HCV screening practices and prevalence in an MCO, 2000–2007. The American journal of managed care. 2011;17(8):548–555. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous
